NEW RECOMMENDATION BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION: All patients with suspected gastritis should be examined by Pepsinogen I, Pepsinogen II and Gastrin-17 biomarkers.
Biohit Oyj press release 15.2.2022 at 10.00 local time (EEST) In December 2021, the Ministry of Health of the Russian Federation made public new official clinical guidelines on the diagnostic practices to be followed for all patients with suspected gastritis or duodenitis (1). According to these new guidelines, “all patients with suspected precancerous changes in the stomach with gastritis (atrophy, intestinal metaplasia) in order to confirm the diagnosis, assess the risk of developing gastric cancer and determine the order of endoscopic observation is